Excelsior Biopharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	185.34	240.08	589.92	895.28	1,103
Short-Term Investments	-	11.45	-	211.19	-
Cash & Short-Term Investments	185.34	251.53	589.92	1,106	1,103
Cash Growth	-26.31%	-57.36%	-46.68%	0.34%	-4.25%
Accounts Receivable	235.04	187.49	160.53	135.03	213.06
Other Receivables	0.67	1.21	2.19	2.95	1.46
Receivables	235.71	188.71	162.73	137.98	214.51
Inventory	285.18	302.93	217.28	188.58	204.6
Other Current Assets	20.01	30.54	14.17	10.09	10.81
Total Current Assets	726.24	773.7	984.09	1,443	1,533
Property, Plant & Equipment	392.51	431.86	445.91	164.61	188.08
Long-Term Investments	91.39	96.4	68.18	69.44	74.14
Other Intangible Assets	0.01	0.03	0.04	0.06	0.07
Long-Term Deferred Tax Assets	18.28	19.94	20.05	20.16	21.23
Other Long-Term Assets	255.58	256.42	59.04	17.59	22.84
Total Assets	1,484	1,578	1,577	1,715	1,839
Accounts Payable	48.03	92.56	45.42	63.75	121.51
Accrued Expenses	-	4.91	4.4	3.99	2.34
Short-Term Debt	159.61	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	297.45	-
Current Portion of Leases	49.76	55.02	53.97	10.75	13.7
Current Income Taxes Payable	3.52	6.93	4.9	3.92	4.1
Other Current Liabilities	110.68	66.35	57.59	78.77	108.62
Total Current Liabilities	371.6	225.77	166.28	458.64	250.27
Long-Term Debt	110	110	-	-	293.99
Long-Term Leases	191.94	245.58	300.25	43.04	56.94
Pension & Post-Retirement Benefits	-	4.57	6.34	5.85	7.7
Other Long-Term Liabilities	6.24	0.98	-	-	-
Total Liabilities	679.78	586.89	472.87	507.53	608.9
Common Stock	473.96	475.64	477.92	475.07	466.67
Additional Paid-In Capital	259.16	256.07	253.78	255.2	263.24
Retained Earnings	81.78	264.88	362.13	453.37	482.6
Treasury Stock	-23.74	-23.74	-23.74	-23.74	-23.74
Comprehensive Income & Other	13.07	18.6	34.36	47.53	41.36
Shareholders' Equity	804.23	991.45	1,104	1,207	1,230
Total Liabilities & Equity	1,484	1,578	1,577	1,715	1,839
Total Debt	511.31	410.59	354.22	351.24	364.63
Net Cash (Debt)	-325.98	-159.07	235.7	755.23	738.13
Net Cash Growth	-	-	-68.79%	2.32%	-5.08%
Net Cash Per Share	-7.07	-3.45	5.13	16.47	15.87
Filing Date Shares Outstanding	46.13	46.75	46.97	46.69	45.85
Total Common Shares Outstanding	46.13	46.75	46.97	46.69	45.85
Working Capital	354.64	547.93	817.81	984.48	1,282
Book Value Per Share	17.44	21.21	23.51	25.86	26.83
Tangible Book Value	804.22	991.42	1,104	1,207	1,230
Tangible Book Value Per Share	17.43	21.21	23.51	25.86	26.83
Land	-	37.26	37.26	37.26	37.26
Buildings	-	72.75	72.75	72.75	72.75
Machinery	-	221.15	221.15	213.92	209.29

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.